Cheng Du Sheng Nuo Biotec Co (SHSE:688117) 3-Year EBITDA Growth Rate : 2.50% (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Cheng Du Sheng Nuo Biotec Co 3-Year EBITDA Growth Rate?

Cheng Du Sheng Nuo Biotec Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.54.

During the past 12 months, Cheng Du Sheng Nuo Biotec Co's average EBITDA Per Share Growth Rate was 24.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 2.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cheng Du Sheng Nuo Biotec Co was 17.00% per year. The lowest was 0.20% per year. And the median was 9.20% per year.

Competitive Comparison of Cheng Du Sheng Nuo Biotec Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cheng Du Sheng Nuo Biotec Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cheng Du Sheng Nuo Biotec Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cheng Du Sheng Nuo Biotec Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cheng Du Sheng Nuo Biotec Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Cheng Du Sheng Nuo Biotec Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cheng Du Sheng Nuo Biotec Co (SHSE:688117) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cheng Du Sheng Nuo Biotec Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cheng Du Sheng Nuo Biotec Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cheng Du Sheng Nuo Biotec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cheng Du Sheng Nuo Biotec Co Ltd (SHSE:688117) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Section 1, Gongye Avenue, Jinyuan Town, Dayi County, Sichuan Province, Chengdu, CHN, 611330

Website

http://www.snbiopharm.com

Cheng Du Sheng Nuo Biotec Co Ltd is a independent research and development, production and sales of peptide raw materials and preparation products.

Executives

Wang Xiao Li	Directors, senior managers
Lu Chang Liang	senior management
Dong Hua Jian	Core technical personnel
Wen Yong Jun	Directors, senior managers, core technical personnel
Wu Li	Directors, senior managers
Guo De Wen	Core technical personnel
Yu Xiao Hai	Directors, senior managers
Ma Zhong Gang	Senior management, core technical personnel
Zhang Hong Yan	Directors, senior managers

Cheng Du Sheng Nuo Biotec Co Headlines

No Headlines